Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2011, Vol. 31 Issue (01): 24-28    
研究报告     
人血管抑素 Kringles 1-3 的表达纯化及生物学活性研究
李壮林1, 姚雪静2, 原桂勇1
1. 山东先声麦得津生物制药有限公司 烟台 264006;
2. 烟台荣昌生物工程有限公司 烟台 264006
Expression, Purification and Bioactivity Research of Human Angiostatin Kringles 1-3
LI Zhuang-lin1, YAO Xue-jing2, YUAN Gui-yong1
1. Shandong Simcere-Medgenn Bio-Pharmaceutical Co., Ltd., Yantai 264006, China;
2. Yantai Rongchang Bioengineering Co., Ltd., Yantai 264006, China
 全文: PDF(496 KB)   HTML
摘要:

人血管抑素包含了4个环饼状结构域(Kringle),是一个有效的血管生成抑制因子。采用PCR方法从人胚肝cDNA文库中扩增了人血管抑素Kringles 1-3的基因,重组于pPIC9K载体中,获得重组载体pPIC9K-K1-3,然后转化毕赤酵母细胞GS115,获得重组菌株。K1-3蛋白在5 L发酵罐的表达量达41.2 mg/L,发酵液上清经过浓缩、透析,然后用Lysine Sepharose 4B层析柱纯化,得到的K1-3蛋白纯度大于98%,纯化回收率达到95%以上。K1-3能明显抑制bFGF刺激的人微血管内皮细胞的迁移,达到抑制效果为50%时所需的蛋白浓度(IC50)为1.86 μg/ml。K1-3也能抑制鸡胚绒毛尿囊膜血管的生长,抑制率达95%。为应用人血管抑素Kringles 1-3治疗肿瘤奠定了初步实验基础。

关键词: 人血管抑素表达纯化活性研究毕氏酵母    
Abstract:

Human angiostatin is composed of 1-4 kringles of plasminogen, which can inhibit the angiogenesis of tumor, the tumor growth and metastasis through preventing tumor's blood and nutrition from supplying. The complete encoding cDNA of human angiostatin Kringles 1-3 was isolated from human embryo liver with PCR and inserted to pPIC9K vector. Then, K1-3 was expressed in secretory P.pastoris expression system by induction of methanol and the expression yield of K1-3 in 5 L fermenter was 41.2 mg/L. The supernatant of cultivation liquid was collected, then concentrated and dialyzed. Recombinant human K1-3 was purified by affinity chromatography with Lysine Sepharose 4B. As a result, HPLC showed purity of K1-3 was more than 98% and the recovery yield was more than 95%. Recombinant human K1-3 inhibited significantly the migration of human microvascular endothelial cells and half inhibitory concentration was 1.86μg/ml. Research showed that K1-3 suppressed specifically the angiogenesis on the CAMs with 95% inhibition.

Key words: Human angiostatin    Expression    Purification    Bioactivity    Pichia pastoris
收稿日期: 2010-08-11 出版日期: 2011-01-25
ZTFLH:  Q789  
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
李壮林
姚雪静
原桂勇

引用本文:

李壮林, 姚雪静, 原桂勇. 人血管抑素 Kringles 1-3 的表达纯化及生物学活性研究[J]. 中国生物工程杂志, 2011, 31(01): 24-28.

LI Zhuang-lin, YAO Xue-jing, YUAN Gui-yong. Expression, Purification and Bioactivity Research of Human Angiostatin Kringles 1-3. China Biotechnology, 2011, 31(01): 24-28.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/        https://manu60.magtech.com.cn/biotech/CN/Y2011/V31/I01/24


[1] Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med, 1995, 1 (1): 27.

[2] O'Reilly M S, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 1994, 79 (2): 315-328.

[3] Ma H I, Guo P, Li J, et al. Suppression of intracranical human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin. Cancer Res, 2002, 62 (3): 756-763.

[4] Schmitz V, Raskopf E, Gonzalez-Carmona M A, et al. Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model. Gut, 2007, 56 (2): 271-278.

[5] Schmitz V, Raskopf E, Gonzalez-Carmona M A, et al. Plasminogen derivatives encoding kringles 1-4 and kringles 1-5 exert indirect antiangiogenic and direct antitumoral effects in experimental lung cancer. Cancer Invest, 2008, 26 (5): 464-470.

[6] Takahashi S, Shinya T, Sugiyama A. Angiostatin inhibition of vascular endothelial growth factor-stimulated nitric oxide production in endothelial cells. J Pharmacol Sci, 2010, 112 (4): 432-437.

[7] Cao Y, Richard W J,Von D, et al. Kringle domains of human angiostatin. J Bio Chem, 1996, 271 (46): 29461-29467.

[8] 付生法, 陆应麟, 张朝山, 等. 检测血管生长因子作用的鸡胚绒毛尿囊膜技术. 军事医学科学院院刊, 1993, 17 (4): 294-297. Fu S F, Lu Y L, Zhang C S, et al. Bull Acad Mil Med Sci, 1993, 17 (4): 294-297.

[9] 李壮林, 常国栋, 陈倩洁, 等. 人基质金属蛋白酶-2 C端片段PEX的高效表达及活性研究. 中国生物工程杂志, 2005, 25(8): 82-86. Li Z L, Chang G D, Chen Q J, et al. China Biotechnology, 2005, 25(8): 82-86.

[10] Morikawa W, Yamamoto K, Ishikawa S , et al . Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells. J Biol Chem, 2000, 275 (49): 38912-38920.

[11] Moser T L, Stack M S, Asplin I, et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Nat Acad Sci, 1999, 96 (6): 2811-2816.

[12] Troyanovsky B, Levchenko T, Mansson G, et al. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol, 2001, 152 (6): 1247-1254.

[13] Tarui T, Miles L A, Takada Y. Specific Interaction of Angiostatin with Integrin alpha vbeta 3 in Endothelial Cell. J Biol Chem, 2001, 276 (43): 39562-39568.

[14] 姚雪静, 李壮林, 常国栋, 等. 人血管内皮抑制素在毕赤酵母中的表达纯化及活性测定. 中国生物工程杂志, 2006, 26(4): 32-35. Yao X J, Li Z L, Chang G D, et al. China Biotechnology, 2006, 26 (4): 32-35.

[1] 贺立恒,张毅,张洁,任豫超,解红娥,唐锐敏,贾小云,武宗信. 基于转录组和WGCNA的甘薯花青素合成相关基因共表达网络的构建及核心基因的挖掘*[J]. 中国生物工程杂志, 2021, 41(9): 27-36.
[2] 乔圣泰,王曼琦,徐慧妮. 番茄SlTpx原核表达蛋白的体外功能分析*[J]. 中国生物工程杂志, 2021, 41(8): 25-32.
[3] 张玲,曹小丹,杨海旭,李文蕾. 连续流层析技术在亲和层析中的应用及生产放大评估[J]. 中国生物工程杂志, 2021, 41(6): 38-44.
[4] 李冰,张传波,宋凯,卢文玉. 生物合成稀有人参皂苷的研究进展*[J]. 中国生物工程杂志, 2021, 41(6): 71-88.
[5] 王惠临,周凯强,朱红雨,王力景,杨仲璠,徐明波,曹荣月. 凝血因子VII及其重组表达新进展[J]. 中国生物工程杂志, 2021, 41(2/3): 129-137.
[6] 张磊,唐永凯,李红霞,李建林,徐逾鑫,李迎宾,俞菊华. 促进原核表达蛋白可溶性的研究进展 *[J]. 中国生物工程杂志, 2021, 41(2/3): 138-149.
[7] 刘美琴,高博,焦月盈,李玮,虞结梅,彭向雷,郑妍鹏,付远辉,何金生. 人呼吸道合胞病毒感染的A549细胞中长链非编码RNA表达谱研究[J]. 中国生物工程杂志, 2021, 41(2/3): 7-13.
[8] 杨茜,栾雨时. sly-miR399在番茄抗晚疫病中的初步探究*[J]. 中国生物工程杂志, 2021, 41(11): 23-31.
[9] 陈素芳,夏明印,曾丽艳,安晓琴,田敏芳,彭建. 抗菌肽Cec4a的重组表达和抗菌活性研究*[J]. 中国生物工程杂志, 2021, 41(10): 12-18.
[10] 石鹏程, 纪晓俊. 酵母系统表达人表皮生长因子研究进展 *[J]. 中国生物工程杂志, 2021, 41(1): 72-79.
[11] 饶海密,梁冬梅,李伟国,乔建军,财音青格乐. 真菌芳香聚酮化合物的合成生物学研究进展*[J]. 中国生物工程杂志, 2020, 40(9): 52-61.
[12] 邓通,周海胜,吴坚平,杨立荣. 基于分子伴侣策略提高NADPH依赖型醇脱氢酶的异源可溶性表达 *[J]. 中国生物工程杂志, 2020, 40(8): 24-32.
[13] 张潇航,李媛媛,贾敏晅,顾奇. 弹性蛋白样生物材料的制备及性质鉴定 *[J]. 中国生物工程杂志, 2020, 40(8): 33-40.
[14] 吕一凡,李更东,薛楠,吕国梁,时邵辉,王春生. LbCpf1基因的原核表达、纯化与体外切割检测 *[J]. 中国生物工程杂志, 2020, 40(8): 41-48.
[15] 蒋丹丹,王云龙,李玉林,张怡青. 含RGD修饰的病毒样颗粒递送ICG靶向肿瘤的研究 *[J]. 中国生物工程杂志, 2020, 40(7): 22-29.